A compound or pharmaceutically acceptable salts thereof of Formula (I)
wherein the substituents are as defined herein, which are useful as kinase inhibitors.
The present invention relates to a 8-azabicyclo[3.2.1] octane derivative of Formula I,
wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt thereof or solvate thereof. The present invention also relates to a pharmaceutical composition comprising an 8-azabicyclo [-3.2.1] octane derivative in admixture with one or more pharmaceutically acceptable auxiliaries and to the use of the 8-azabicyclo[3.2.1] octane derivative in therapy.